Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: May 19, 2026, 4:00 PM EDT
2.770
+0.030 (1.09%)
After-hours: May 19, 2026, 7:42 PM EDT
Altimmune Stock Forecast
ALT's stock price has decreased by -50.9% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 10 analysts polled by S&P Global, Altimmune stock has a consensus rating of "Buy" and an average price target of $16.06. The average 1-year stock price forecast is 486.13% higher than the current stock price, while the lowest is $2.50 (-8.76%) and the highest is $28 (+921.90%).
Price Target: $16.06 (+486.13%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Altimmune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +629.93% | May 18, 2026 |
| Citizens | Citizens | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +301.46% | May 14, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $25 | Strong Buy | Maintains | $12 → $25 | +812.41% | Mar 16, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +374.45% | Mar 6, 2026 |
| Citizens | Citizens | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +410.95% | Nov 7, 2025 |
Financial Forecast
Revenue This Year
7.07K
from 41.00K
Decreased by -82.76%
Revenue Next Year
n/a
from 7.07K
EPS This Year
-0.92
from -1.00
EPS Next Year
-0.95
from -0.92
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 43,050 | n/a | ||||||
| Avg | 7,070 | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.0% | - | ||||||
| Avg | -82.8% | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.62 | -0.47 | ||||||
| Avg | -0.92 | -0.95 | ||||||
| Low | -1.08 | -1.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.